EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases

Ten key recommendations for the management of systemic GC-therapy were formulated using a combination of systematically retrieved research evidence and expert consensus. There are areas of importance that have little evidence (ie, dosing and tapering strategies, timing, risk factors and monitoring for adverse effects, perioperative GC-replacement) and need further research; therefore also a research agenda was composed.

Authors: Hoes, J. N.; Jacobs, J. W.; Boers, M.; Boumpas, D.; Buttgereit, F.; Caeyers, N.; Choy, E. H.; Cutolo, M.; Da Silva, J. A.; Esselens, G.; Guillevin, L.; Hafstrom, I.; Kirwan, J. R.; Rovensky, J.; Russell, A.; Saag, K. G.; Svensson, B.; Westhovens, R.; Zeidler, H.; Bijlsma, J. W. 

Title: EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases

Year: 2007

Journal: Ann Rheum Dis

Volume: 66

Issue : 12

Pages: 1560-7

Pubmed Link: Click here.